Sanara MedTech Inc. Share Price & Technical Analysis
SMTI · $23.17 (-1.99%)
Healthcare / Medical Instruments & Supplies
$23.17
-1.99%
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and secon…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
25% return in May, -11% avg return in past 3 year May month.
7% return in 2026, -7% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -8% | -7% | -14% | 11% | 25% | – | – | – | – | – | – | – | 7% |
| 25 | 9% | -1% | -11% | 4% | -9% | -3% | -14% | 40% | -5% | -7% | -28% | 14% | -13% |
| 24 | -17% | 11% | -3% | -12% | -6% | -6% | 14% | 15% | -14% | 9% | 10% | -9% | -7% |
| 23 | -4% | -3% | -1% | 1% | -19% | 19% | 6% | -15% | -15% | -12% | 18% | 24% | -1% |
| 22 | -21% | 2% | 14% | -12% | -11% | -3% | 27% | 33% | -13% | -3% | 23% | 20% | 56% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect; ACTIGEN Inductive Bone Matrix, a naturally derived, differentiated allograft matrix with robust handling properties; ALLOCYTE Plus, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers; and TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement. The company has a license agreement with Rochal to develop, market, and sell antimicrobial products that include BIASURGE Advanced Surgical Solution, BIAKOS Antimicrobial Wound Gel, and BIAKOS Antimicrobial Skin and Wound Cleanser for the prevention and treatment of microbes on the human body. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$210.48M
P/E ratio
—
52W high
$35.95
52W low
$16.05
Volume
45,370
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Sanara MedTech Inc. share price today?
- Sanara MedTech Inc. (SMTI) last traded around $23.17 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SMTI have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SMTI. Download the app for real-time alerts.
- How can I analyze Sanara MedTech Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.